BC Innovations | Mar 29, 2017
Distillery Techniques


TECHNOLOGY: Plasma markers Serum levels of a panel of miRNAs could help diagnose radiation exposure and predict survival after total body irradiation. In serum samples taken from 54 monkeys before and after total body irradiation,...
BC Innovations | Oct 6, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-30a (miR-30a)

Autoimmune disease INDICATION: Multiple sclerosis (MS) Mouse studies suggest promoting miR-30a expression with disulfiram or diphenhydramine hydrochloride could help treat MS. In the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, IV injection of a...
BC Innovations | Oct 21, 2010
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Rett syndrome Methyl CpG binding protein 2 (MECP2; RTT); microRNA-30a (miR-30a); miR-30d; miR-381; miR-495; brain-derived neurotrophic factor (BDNF) Mouse studies suggest that inhibiting miRNAs that...
Items per page:
1 - 3 of 3